Published in United European Gastroenterol J on October 30, 2015
Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol (2017) 0.75
Cholangitis: Diagnosis, Treatment and Prognosis. J Clin Transl Hepatol (2017) 0.75
Complications of endoscopic biliary sphincterotomy. N Engl J Med (1996) 11.10
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc (1998) 6.51
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol (2009) 4.45
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol (2001) 4.14
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol (2002) 3.72
Diagnosis and management of primary sclerosing cholangitis. Hepatology (2010) 3.60
Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc (2009) 3.30
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology (2009) 2.75
Complications of ERCP: a prospective study. Gastrointest Endosc (2004) 2.61
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study. Aliment Pharmacol Ther (2013) 1.79
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr (2008) 1.20
Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology (2003) 1.07
Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology (2010) 1.05
Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol (2011) 1.02
A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol (2008) 0.99
Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology (2013) 0.97
Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology (1995) 0.89
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis. Endoscopy (2010) 0.82
Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy (2012) 0.82
Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol (2014) 0.78
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol (2016) 0.81
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites. Clin Gastroenterol Hepatol (2016) 0.77
Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors. Anticancer Res (2015) 0.77
HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors. APMIS (2016) 0.75
Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo). BMJ Open (2017) 0.75
MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans. J Hepatol (2020) 0.75
Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013. Int J Cancer (2016) 0.75
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. J Hepatol (2017) 0.75